|
1
|
Alberg AJ, Ford JG and Samet JM: American
College of Chest Physicians: Epidemiology of lung cancer: ACCP
evidence-based clinical practice guidelines (2nd edition). Chest.
132:(3 Suppl). 29S–55S. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Villeneuve PJ and Mao Y: Lifetime
probability of developing lung cancer, by smoking status, Canada.
Can J Public Health. 85:385–388. 1994.PubMed/NCBI
|
|
3
|
Zhang R, Chu M, Zhao Y, Wu C, Guo H, Shi
Y, Dai J, Wei Y, Jin G, Ma H, et al: A genome-wide gene-environment
interaction analysis for tobacco smoke and lung cancer
susceptibility. Carcinogenesis. 35:1528–1535. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Coussens LM and Werb Z: Inflammation and
cancer. Nature. 420:860–867. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kamp DW, Shacter E and Weitzman SA:
Chronic inflammation and cancer: The role of the mitochondria.
Oncology (Williston Park). 25:400–410, 413. 2011.PubMed/NCBI
|
|
6
|
Grivennikov SI and Karin M: Inflammation
and oncogenesis: A vicious connection. Curr Opin Genet Dev.
20:65–71. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Takizawa H, Tanaka M, Takami K, Ohtoshi T,
Ito K, Satoh M, Okada Y, Yamasawa F and Umeda A: Increased
expression of inflammatory mediators in small-airway epithelium
from tobacco smokers. Am J Physiol Lung Cell Mol Physiol.
278:L906–L913. 2000.PubMed/NCBI
|
|
8
|
Xie K: Interleukin-8 and human cancer
biology. Cytokine Growth Factor Rev. 12:375–391. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Masuya D, Huang C, Liu D, Kameyama K,
Hayashi E, Yamauchi A, Kobayashi S, Haba R and Yokomise H: The
intratumoral expression of vascular endothelial growth factor and
interleukin-8 associated with angiogenesis in nonsmall cell lung
carcinoma patients. Cancer. 92:2628–2638. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Grivennikov SI, Greten FR and Karin M:
Immunity, inflammation, and cancer. Cell. 140:883–899. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Huang D, Yang L, Liu Y, Zhou Y, Guo Y, Pan
M, Wang Y, Tan Y, Zhong H, Hu M, et al: Functional polymorphisms in
NFkB1/IkBa predict risks of chronic obstructive pulmonary disease
and lung cancer in Chinese. Hum Genet. 132:451–460. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tang X, Liu D, Shishodia S, Ozburn N,
Behrens C, Lee JJ, Hong WK, Aggarwal BB and Wistuba II: Nuclear
factor-kappaB (NF-kappaB) is frequently expressed in lung cancer
and preneoplastic lesions. Cancer. 107:2637–2646. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lambeth JD: Nox enzymes, ROS, and chronic
disease: An example of antagonistic pleiotropy. Free Radic Biol
Med. 43:332–347. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bedard K, Attar H, Bonnefont J, Jaquet V,
Borel C, Plastre O, Stasia MJ, Antonarakis SE and Krause KH: Three
common polymorphisms in the CYBA gene form a haplotype associated
with decreased ROS generation. Hum Mutat. 30:1123–1133. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ushio-Fukai M and Nakamura Y: Reactive
oxygen species and angiogenesis: NADPH oxidase as target for cancer
therapy. Cancer Lett. 266:37–52. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hussain SP, Hofseth LJ and Harris CC:
Radical causes of cancer. Nat Rev Cancer. 3:276–285. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ross D, Kepa JK, Winski SL, Beall HD,
Anwar A and Siegel D: NAD(P)H: Quinone oxidoreductase 1 (NQO1):
Chemoprotection, bioactivation, gene regulation and genetic
polymorphisms. Chem Biol Interact. 129:77–97. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Joseph P and Jaiswal AK: NAD(P)H: Quinone
oxidoreductase1 (DT diaphorase) specifically prevents the formation
of benzo[a]pyrene quinone-DNA adducts generated by cytochrome
P4501A1 and P450 reductase. Proc Natl Acad Sci USA. 91:8413–8417.
1994. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
De Flora S, Bennicelli C, D'Agostini F,
Izzotti A and Camoirano A: Cytosolic activation of aromatic and
heterocyclic amines. Inhibition by dicoumarol and enhancement in
viral hepatitis B. Environ Health Perspect. 102:(Suppl 6). S69–S74.
1994. View
Article : Google Scholar
|
|
20
|
Eom SY, Zhang YW, Kim SH, Choe KH, Lee KY,
Park JD, Hong YC, Kim YD, Kang JW and Kim H: Influence of NQO1,
ALDH2, and CYP2E1 genetic polymorphisms, smoking, and alcohol
drinking on the risk of lung cancer in Koreans. Cancer Causes
Control. 20:137–145. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Dinkova-Kostova AT and Talalay P:
NAD(P)H:quinone acceptor oxidoreductase 1 (NQO1), a multifunctional
antioxidant enzyme and exceptionally versatile cytoprotector. Arch
Biochem Biophys. 501:116–123. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Meyer ML, Potts-Kant EN, Ghio AJ, Fischer
BM, Foster WM and Voynow JA: NAD(P)H quinone oxidoreductase 1
regulates neutrophil elastase-induced mucous cell metaplasia. Am J
Physiol Lung Cell Mol Physiol. 303:L181–L188. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Engels EA, Wu X, Gu J, Dong Q, Liu J and
Spitz MR: Systematic evaluation of genetic variants in the
inflammation pathway and risk of lung cancer. Cancer Res.
67:6520–6527. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Engels EA: Inflammation in the development
of lung cancer: Epidemiological evidence. Expert Rev Anticancer
Ther. 8:605–615. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kiyohara C, Horiuchi T, Takayama K and
Nakanishi Y: Genetic polymorphisms involved in the inflammatory
response and lung cancer risk: A case-control study in Japan.
Cytokine. 65:88–94. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chaturvedi AK, Caporaso NE, Katki HA, Wong
HL, Chatterjee N, Pine SR, Chanock SJ, Goedert JJ and Engels EA:
C-reactive protein and risk of lung cancer. J Clin Oncol.
28:2719–2726. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tuncay Senol S, Okyay P and Bardakci F:
Identification of NF-kappaB1 and NF-kappaBIAlpha polymorphisms
using PCR-RFLP assay in a Turkish population. Biochem Genet.
48:104–112. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Johnson VJ, Yucesoy B and Luster MI:
Genotyping of single nucleotide polymorphisms in cytokine genes
using real-time PCR allelic discrimination technology. Cytokine.
27:135–141. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
http://www.kenkounippon21.gr.jp/kenkounippon21/about/kakuron/index.html
|
|
30
|
Andersson T, Alfredsson L, Källberg H,
Zdravkovic S and Ahlbom A: Calculating measures of biological
interaction. Eur J Epidemiol. 20:575–579. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Peng WJ, He Q, Yang JX, Wang BX, Lu MM,
Wang S and Wang J: Meta-analysis of association between cytokine
gene polymorphisms and lung cancer risk. Mol Biol Rep.
39:5187–5194. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Taguchi A, Ohmiya N, Shirai K, Mabuchi N,
Itoh A, Hirooka Y, Niwa Y and Goto H: Interleukin-8 promoter
polymorphism increases the risk of atrophic gastritis and gastric
cancer in Japan. Cancer Epidemiol Biomarkers Prev. 14:2487–2493.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Sugimoto Y, Wakai K, Nakagawa H, Suma S,
Sasakabe T, Sakamoto T, Takashima N, Suzuki S, Ogawa S, Ohnaka K,
et al: Associations between polymorphisms of interleukin-6 and
related cytokine genes and serum liver damage markers: A
cross-sectional study in the Japan multi-institutional
collaborative cohort (J-MICC) study. Gene. 557:158–162. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Shirai K, Ohmiya N, Taguchi A, Mabuchi N,
Yatsuya H, Itoh A, Hirooka Y, Niwa Y, Mori N and Goto H:
Interleukin-8 gene polymorphism associated with susceptibility to
non-cardia gastric carcinoma with microsatellite instability. J
Gastroenterol Hepatol. 21:1129–1135. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lou Y, Li R, Xiong L, Gu A, Shi C, Chu T,
Zhang X, Gu P, Zhong H, Wen S and Han B: NAD(P)H: quinone
oxidoreductase 1 (NQO1) C609T polymorphism and lung cancer risk: A
meta-analysis. Tumour Biol. 34:3967–3979. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Traver RD, Siegel D, Beall HD, Phillips
RM, Gibson NW, Franklin WA and Ross D: Characterization of a
polymorphism in NAD(P)H: Quinone oxidoreductase (DT-diaphorase). Br
J Cancer. 75:69–75. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Lee PN, Forey BA and Coombs KJ: Systematic
review with meta-analysis of the epidemiological evidence in the
1900s relating smoking to lung cancer. BMC Cancer. 12:3852012.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Prawan A, Buranrat B, Kukongviriyapan U,
Sripa B and Kukongviriyapan V: Inflammatory cytokines suppress NAD
(P)H:quinone oxidoreductase-1 and induce oxidative stress in
cholangiocarcinoma cells. J Cancer Res Clin Oncol. 135:515–522.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Asher G, Lotem J, Cohen B, Sachs L and
Shaul Y: Regulation of p53 stability and p53-dependent apoptosis by
NADH quinone oxidoreductase 1. Proc Natl Acad Sci USA.
98:1188–1193. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Levine AJ: p53, the cellular gatekeeper
for growth and division. Cell. 88:323–331. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Siegel D, Anwar A, Winski SL, Kepa JK,
Zolman KL and Ross D: Rapid polyubiquitination and proteasomal
degradation of a mutant form of NAD(P)H:quinone oxidoreductase 1.
Mol Pharmacol. 59:263–268. 2001.PubMed/NCBI
|
|
42
|
Guzik TJ, West NE, Black E, McDonald D,
Ratnatunga C, Pillai R and Channon KM: Functional effect of the
C242T polymorphism in the NAD(P)H oxidase p22phox gene on vascular
superoxide production in atherosclerosis. Circulation.
102:1744–1747. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Campa D, Hung RJ, Mates D, Zaridze D,
Szeszenia-Dabrowska N, Rudnai P, Lissowska J, Fabiánová E, Bencko
V, Foretova L, et al: Lack of association between −251 T>A
polymorphism of IL8 and lung cancer risk. Cancer Epidemiol
Biomarkers Prev. 14:2457–2458. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Wang Y, Chen L, Pan L, Xue J and Yu H: The
association between NFKB1-94ins/del ATTG polymorphism and non-small
cell lung cancer risk in a Chinese Han population. Int J Clin Exp
Med. 8:8153–8157. 2015.PubMed/NCBI
|
|
45
|
Oltulu YM, Coskunpinar E, Ozkan G, Aynaci
E, Yildiz P, Isbir T and Yaylim I: Investigation of NF-kB1 and
NF-kBIA gene polymorphism in non-small cell lung cancer. Biomed Res
Int. 2014:5303812014. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Orosz Z, Csiszar A, Labinskyy N, Smith K,
Kaminski PM, Ferdinandy P, Wolin MS, Rivera A and Ungvari Z:
Cigarette smoke-induced proinflammatory alterations in the
endothelial phenotype: Role of NAD(P)H oxidase activation. Am J
Physiol Heart Circ Physiol. 292:H130–H139. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Jaimes EA, DeMaster EG, Tian RX and Raij
L: Stable compounds of cigarette smoke induce endothelial
superoxide anion production via NADPH oxidase activation.
Arterioscler Thromb Vasc Biol. 24:1031–1036. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Heikkilä K, Harris R, Lowe G, Rumley A,
Yarnell J, Gallacher J, Ben-Shlomo Y, Ebrahim S and Lawlor DA:
Associations of circulating C-reactive protein and interleukin-6
with cancer risk: Findings from two prospective cohorts and a
meta-analysis. Cancer Causes Control. 20:15–26. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Chu AY, Guilianini F, Barratt BJ, Nyberg
F, Chasman DI and Ridker PM: Pharmacogenetic determinants of
statin-induced reductions in C-reactive protein. Circ Cardiovasc
Genet. 5:58–65. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
dos santos Silva I: Case-control
studiesCancer Epidemiology: Principles and Methods. IARC Press;
Lyon: pp. 189–212. 1999
|
|
51
|
Morton LM, Cahill J and Hartge P:
Reporting participation in epidemiologic studies: A survey of
practice. Am J Epidemiol. 163:197–203. 2006. View Article : Google Scholar : PubMed/NCBI
|
